National Health Act (Pharmaceutical Benefits – Early Supply) Amendment June 2011 specification under subsection 84AAA(2) (No. PB 41 of 2011) (Cth)

COMMONWEALTH OF AUSTRALIA

Instrument number PB 41 of 2011

National Health Act (Pharmaceutical Benefits – Early Supply) Amendment June 2011 - Specification Under Subsection 84AAA(2)

Amendment determination under subsection 84AAA(2) of the National Health Act 1953

I, Adriana Platona, Assistant Secretary, Pharmaceutical Evaluation Branch, Department of Health and Ageing, delegate of the Minister for Health and Ageing, make this Instrument under subsection 84AAA(2) of the National Health Act 1953.

Dated 19 May 2011

ADRIANA PLATONA

Assistant Secretary

Pharmaceutical Evaluation Branch

Department of Health and Ageing

Amendment determination — Pharmaceutical Benefits - Early Supply

1          Name of Instrument

(1)      This Instrument is the National Health Act (Pharmaceutical Benefits – Early Supply) Amendment June 2011 - specification under subsection 84AAA(2).

(2)      This Instrument may also be cited as No. PB 41 of 2011.

2          Commencement

This Instrument commences on 1 June 2011.

3          Amendment of PB 30 of 2009

Schedule 1 amends the National Health (Pharmaceutical Benefits – Early Supply) Instrument 2009- specification under subsection 84AAA(2), PB 30 of 2009.

Schedule 1        Amendments

1. Schedule 1, after item dealing with Risedronic acid, Tablet 35 mg

insert in the columns in the order indicated:

Tablet (enteric coated) containing risedronate sodium 35mg Oral 4 5

1. Schedule 1, after item dealing with Risedronic acid

omit:

Risedronate sodium and calcium carbonate	Pack containing 4 tablets risedronate sodium 35 mg and 24 tablets calcium carbonate 1.25 g (equivalent to 500 mg calcium)	Oral	1	5
Risedronate sodium and calcium carbonate with colecalciferol	Pack containing 4 tablets risedronate sodium 35 mg and 24 sachets containing granules of calcium carbonate 2.5 g (equivalent to 1 g calcium) with colecalciferol 22 micrograms	Oral	1	5

1. Schedule 1, after item dealing with Risedronic acid and calcium, Pack containing 4 tablets risedronate sodium 35 mg and 24 tablets calcium 500 mg (as carbonate)

insert in the columns in the order indicated:

Pack containing 4 enteric coated tablets risedronate sodium 35 mg and 24 tablets calcium 500 mg (as carbonate) Oral 1 5

1. Schedule 1, after item dealing with Risedronic acid and calcium with colecalciferol, Pack containing 4 tablets risedronate sodium 35 mg and 24 sachets containing granules of calcium carbonate 2.5 g with colecalciferol 22 micrograms

insert in the columns in the order indicated:

Pack containing 4 enteric coated tablets risedronate sodium 35 mg and 24 sachets containing granules of calcium carbonate 2.5 g with colecalciferol 22 micrograms Oral 1 5

1. Schedule 1, after item dealing with Telmisartan

insert in the columns in the order indicated:

Telmisartan with amlodipine	Tablet 40 mg-5 mg (as besylate)	Oral	28	5
	Tablet 40 mg-10 mg (as besylate)	Oral	28	5
	Tablet 80 mg-5 mg (as besylate)	Oral	28	5
	Tablet 80 mg-10 mg (as besylate)	Oral	28	5